We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

APO:NYSEApollo Global Management, Inc. (New) Analysis

Data as of 2026-08-10 - not real-time

$129.85

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Apollo Global Management, Inc. is bearish at $129.85, with short-term averages lagging the long-term ones. Across the trailing 30 sessions it gained 9.8%. Momentum indicators put RSI at 58.4 (neutral) with MACD reading bullish. Watch $116.57 as support and $135.37 as the nearer resistance level.
On valuation the read is overvalued — earnings multiple of 46.4 versus a 16.9 sector average, above the peer group. Consensus targets land 17.3% above where the shares trade now. Revenue is growing at 63.8% on a 5.3% profit margin. The 1.77% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 32.8%, a beta of 1.16 and a maximum drawdown of 34.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.

Top Market Events

Apollo Global Management, Inc. NYSE:APO reported second-quarter 2026 results that featured stronger-than-expected...Apollo Global Management NYSE:APO has completed a £5.NEW YORK, Aug. 04, 2026 GLOBE NEWSWIRE -- Apollo Global Management, Inc. NYSE: APO together with its consolidated...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading above the 200-day average of 127.08
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 46.4 versus sector average of 16.9
  • Trading above the 200-day average of 127.08

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 46.4 versus sector average of 16.9
  • Analyst targets imply +17.3% versus the current price
  • Revenue growth of +63.8%

Key Metrics & Analysis

Financial Health

Revenue Growth63.80%
Profit Margin5.27%
P/E Ratio46.4
ROE11.41%
ROA0.94%
Debt/Equity33.09
P/B Ratio3.8
Industry P/E16.9

Technical Analysis

TrendBearish
RSI58.4
Support$116.57
Resistance$135.37
MA 20$123.75
MA 50$125.38
MA 200$127.08
MACDBullish
VolumeStable
Fear & Greed Index94.09

Valuation

Target Price$152.32
Upside/Downside17.30%
GradeOvervalued
TypeGrowth
Dividend Yield1.77%

Risk Assessment

Beta1.16
Volatility32.82%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.